Results 31 to 40 of about 321,270 (256)

Matlab Class for Rapid Visualization of Missile-Target Engagement Scenarios [PDF]

open access: yesProblemy Mechatroniki, 2023
In this paper, the authorial Matlab Battlespace Visualization Class (MBVC) is proposed to plan, design, and compose the preliminary version of the desired computer animation, which can then be used both as a background for the discussion of the final ...
Witold BUŻANTOWICZ (witold.buzantowicz@wat.edu.pl)
doaj   +1 more source

Quantification of Trastuzumab–HER2 Engagement In Vitro and In Vivo

open access: yesMolecules, 2020
Human EGF Receptor 2 (HER2) is an important oncogene driving aggressive metastatic growth in up to 20% of breast cancer tumors. At the same time, it presents a target for passive immunotherapy such as trastuzumab (TZM).
Alena Rudkouskaya   +3 more
doaj   +1 more source

A high content, high throughput cellular thermal stability assay for measuring drug-target engagement in living cells. [PDF]

open access: yesPLoS ONE, 2018
Determining and understanding drug target engagement is critical for drug discovery. This can be challenging within living cells as selective readouts are often unavailable.
Andrew J Massey
doaj   +1 more source

In Situ Target Engagement Studies in Adherent Cells [PDF]

open access: yesACS Chemical Biology, 2018
A prerequisite for successful drugs is effective binding of the desired target protein in the complex environment of a living system. Drug-target engagement has typically been difficult to monitor in physiologically relevant models, and with current methods, especially, while maintaining spatial information.
Hanna Axelsson   +8 more
openaire   +4 more sources

Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2

open access: yesCell Reports Medicine
Summary: Matrix stiffening by lysyl oxidase-like 2 (LOXL2)-mediated collagen cross-linking is proposed as a core feedforward mechanism that promotes fibrogenesis.
Joseph A. Bell   +24 more
doaj   +1 more source

Dose escalation PET imaging for safety and effective therapy dose optimization of a bispecific antibody

open access: yesmAbs, 2020
Selecting the dose for efficacy and first-in-human studies of bispecific antibodies (BsAbs) is a challenging process. Herein, positron emission tomography (PET) imaging with 89Zr-labeled IBI322, an anti-CD47/PD-L1 BsAb, was used to optimize the safety ...
Yan Wang   +13 more
doaj   +1 more source

T-cell engagers: model interrogation as a tool to quantify the interplay of relative affinity and target expression on trimer formation

open access: yesFrontiers in Pharmacology
T-cell engagers (TCEs) represent a promising therapeutic strategy for various cancers and autoimmune disorders. These bispecific antibodies act as bridges, connecting T-cell receptors (TCRs) to target cells (either malignant or autoreactive) via ...
Massimo Lai   +5 more
doaj   +1 more source

Articulating ethical principles guiding Target Malaria's engagement strategy

open access: yesMalaria Journal, 2022
Progress in gene drive research has engendered a lively discussion about community engagement and the ethical standards the work hinges on. While there is broad agreement regarding ethical principles and established best practices for conducting clinical
Aaron J. Roberts, Delphine Thizy
doaj   +1 more source

Resistance to kinase inhibition through shortened target engagement

open access: yesMolecular & Cellular Oncology, 2022
Imatinib, a selective inhibitor of the breakpoint cluster region (BCR)-ABL kinase, is the poster child for targeted cancer therapeutics. However, its efficacy is limited by resistance mutations.
Aziz M. Rangwala   +4 more
doaj   +1 more source

Maximizing brain networks engagement via individualized connectome-wide target search

open access: yesBrain Stimulation, 2022
Background: In recent years, the possibility to noninvasively interact with the human brain has led to unprecedented diagnostic and therapeutic opportunities.
Arianna Menardi   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy